Advertisement

Topics

Zogenix’ drug cuts seizures in Dravet syndrome

19:32 EDT 12 Jul 2018 | PharmaTimes

Zogenix has revealed top-line results from a second late-stage trial of its investigational Dravet syndrome drug ZX008, showing a significant reduction in seizures.

Original Article: Zogenix’ drug cuts seizures in Dravet syndrome

NEXT ARTICLE

More From BioPortfolio on "Zogenix’ drug cuts seizures in Dravet syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...